-
Electronic (PDF)
-
Site License
-
Enterprisewide
Weight Management in the Czech Republic
Euromonitor International, April 2012, Pages: 27
Weight management had dynamic value growth with CAGR of 8% over the review period. Nevertheless, this healthy growth was interrupted by outbreak of financial crisis at the end of this period. In 2009, sales of weight management were positively influenced by launch of OTC obesity brand Alli, which had success among Czech consumers and thus supported overall sales of weight management in this year. However, as negative impacts of worsened economic situation persisted in 2010 and 2011, weight...
The Weight Management in Czech Republic report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Meal Replacement Slimming, OTC Obesity, Other Slimming Products, Slimming Teas, Weight Loss Supplements.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Weight Management market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
WEIGHT MANAGEMENT IN THE CZECH REPUBLIC
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Weight Management: Value 2006-2011
Table 2 Sales of Weight Management: % Value Growth 2006-2011
Table 3 Weight Management Company Shares 2007-2011
Table 4 Weight Management Brand Shares 2008-2011
Table 5 Forecast Sales of Weight Management: Value 2011-2016
Table 6 Forecast Sales of Weight Management: % Value Growth 2011-2016
Green Swan Pharmaceuticals Cr As in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 1 Green Swan Pharmaceuticals CR as: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Green Swan Pharmaceuticals CR as: Competitive Position 2011
Walmark As in Consumer Health (czech Republic)
Strategic Direction
Key Facts
Summary 3 Walmark as: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Walmark as: Competitive Position 2011
Executive Summary
Consumer Health Hampered by Worse Economic Situation
Consumers Economise in Order To Reduce Their Expenses
Zentiva, Followed by Domestic Company Walmark, Leads Sales in 2011
Chemists/pharmacies Remains Most Important Distribution Channel
Consumer Health Is Predicted To See Satisfactory Growth Over the Forecast Period
Key Trends and Developments
Ongoing Poor Economic Situation Negatively Impacts Sales of Consumer Health Products
All Leading Producers Maintain Their Value Shares in 2011
Private Label Products Remain Limited
Chemists/pharmacies Remains A Key Distribution Channel
Lifestyle, Growing Interest in Self-medication, Prevention and Rising Health Awareness Are Main Drivers of Sales of Consumer Health
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 5 OTC Switches 2009-2011
Definitions
Sources
Summary 6 Research Sources
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
